TheraVet SA operates as a veterinary biotech company. It specializes in the development and production of treatments for osteoarticular diseases in cats, dogs, and horses. Its products include Biocera-Vet and Visco-Vet. The company was founded by Enrico Bastianelli on November 21, 2017 and s headquartered in Gosselies, Belgium.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company